Hardesty Christina K, Gordon Zachary L, Poe-Kochert Connie, Son-Hing Jochen P, Thompson George H
Rainbow Babies and Children's Hospital, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH.
J Pediatr Orthop. 2018 Feb;38(2):e78-e82. doi: 10.1097/BPO.0000000000001097.
Reducing perioperative blood loss and the need for transfusions in patients undergoing spinal surgery is especially important for those with neuromuscular disorders. These patients require extensive spino-pelvic exposure and are often medically fragile. We have used Amicar to decrease blood loss since 2001. As an effort to further reduce blood loss and transfusions, we use a bipolar sealer device (Aquamantys) as an adjunct to electrocautery. We present the results of our first 64 neuromuscular patients to show the efficacy of the device.
Using a prospectively maintained database we reviewed the operative time, estimated perioperative blood loss, cell saver use, and intraoperative and postoperative transfusion rate in patients who underwent posterior spinal fusion for neuromuscular scoliosis. Sixty-four patients were identified who fit these criteria since the use of the bipolar sealer device was instituted.We compared these patients with a control group of the preceding 65 patients in whom this device was not used for hemostasis. All patients, including those in the study group, received Amicar (infusion of 100 mg/kg over 15 to 20 min, then 10 mg/kg/h throughout the remainder of the procedure). The surgical technique did not differ between the 2 groups.
Baseline characteristics between the 2 groups were similar except for the number of patients having an all-screw construct which was larger in the investigational group (25% vs. 8%, P=0.03). There were no significant differences in operative time or duration of hospital stay. Intraoperative blood loss was lower in the study group (741 mL) as compared with the control group (1052 mL, P=0.003). Total perioperative blood loss, however, showed no significant difference. Thirty-five (55%) patients in the study group and 50 (77%) patients in the control group required additional intraoperative or postoperative transfusions (P=0.01). The number of packed red cell units transfused per patient was 0.81 in the study group and 1.57 in the control group (P=0.001). Although the intraoperative cell saver transfusion was same, the total blood volume transfused, which includes cell saver and any other transfusions, was significantly lower in the study group, 425 mL versus 671 mL (P=0.002).
Use of a bipolar sealer device in posterior spinal fusion for neuromuscular scoliosis significantly reduced intraoperative blood loss and transfusion rate when compared with a control group in this retrospective review.
Level III-retrospective comparative study.
减少脊柱手术患者的围手术期失血以及输血需求,对于患有神经肌肉疾病的患者尤为重要。这些患者需要广泛的脊柱骨盆暴露,且通常身体状况较差。自2001年以来,我们一直使用氨基己酸来减少失血。为了进一步减少失血和输血,我们使用双极密封装置(Aquamantys)作为电灼术的辅助工具。我们展示了首批64例神经肌肉疾病患者的结果,以证明该装置的有效性。
我们使用前瞻性维护的数据库,回顾了接受神经肌肉性脊柱侧弯后路脊柱融合术患者的手术时间、估计的围手术期失血量、细胞回收器的使用情况以及术中及术后输血率。自采用双极密封装置以来,共确定了64例符合这些标准的患者。我们将这些患者与之前65例未使用该装置进行止血的对照组患者进行了比较。所有患者,包括研究组患者,均接受氨基己酸(在15至20分钟内输注100mg/kg,然后在手术剩余时间内以10mg/kg/h的速度输注)。两组的手术技术没有差异。
两组之间的基线特征相似,但全螺钉结构的患者数量在研究组中更多(25%对8%,P = 0.03)。手术时间或住院时间没有显著差异。研究组的术中失血量(741mL)低于对照组(1052mL,P = 0.003)。然而,围手术期总失血量没有显著差异。研究组中有35例(55%)患者和对照组中有50例(77%)患者需要额外的术中或术后输血(P = 0.01)。研究组患者每例输注的红细胞单位数为0.81,对照组为1.57(P = 0.001)。尽管术中细胞回收器输血情况相同,但研究组包括细胞回收器和任何其他输血在内的总输血量显著较低,分别为425mL和671mL(P = 0.002)。
在这项回顾性研究中,与对照组相比,在神经肌肉性脊柱侧弯后路脊柱融合术中使用双极密封装置显著减少了术中失血量和输血率。
III级——回顾性比较研究。